Open AccessPatient Perspectives on Factors Affecting Direct Oral Anticoagulant Use for Stroke Prevention in Atrial Fibrillation
Author(s) -
Kristina Medlinskiene,
Susan Richardson,
Beth Fylan,
Katherine Stirling,
Marcus Rattray,
Duncan Petty
Publication year - 2021
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s302016
Subject(s) - medicine , atrial fibrillation , vitamin k antagonist , oral anticoagulant , intensive care medicine , vitamin k , stroke (engine) , family medicine , adverse effect , warfarin , mechanical engineering , engineering
Oral anticoagulant therapy choices for patients with atrial fibrillation (AF) expanded in the last decade with the introduction of direct oral anticoagulants (DOAC). However, the implementation of DOACs was slow and varied across different health economies in England. There is limited evidence on the patient role in the uptake of new medicines, including DOACs, apart from considering their demographic and clinical characteristics. Hence, this study aimed to address the gap by exploring the view of patients with AF on factors affecting DOAC use.